Default Mode Network


The default mode network (DMN) is a network of active brain regions when the mind is at rest and not focused on the external environment. It is involved in self-referential thinking, introspection, and daydreaming. A hyperconnected default mode network refers to increased connectivity and communication among the brain regions that make up the DMN.

In the context of mental health disorders, such as depression and PTSD, a hyperconnected DMN has been associated with excessive rumination, negative self-referential thoughts, and difficulty disengaging from internal mental processes. This heightened connectivity may contribute to the persistence and severity of symptoms in these conditions.

Ketamine therapy has been shown to influence the connectivity of the DMN in patients with depression and PTSD. Research has indicated that ketamine can rapidly reduce the hyperconnectivity within the DMN, which may be one of the mechanisms through which it exerts its therapeutic effects. By decreasing the connectivity in the DMN, ketamine may help alleviate excessive rumination and negative self-referential thinking, improving symptoms.

Here is an overview of expected default mode network (DMN) changes with therapeutic ketamine, both short-term and long-term, with cited sources:

Short-Term Effects:

A single low-dose ketamine infusion rapidly normalizes dysfunctional connectivity in the DMN in depressed patients. Specific changes include:

  • Increased connectivity between posterior cingulate cortex and medial prefrontal cortex, critical hubs of the DMN [1]
  • Reduced dominance of anterior DMN regions associated with rumination [2]
  • Restoration of a normal inverse relationship between DMN and task-positive network activity [3]

These effects emerge within hours, peak in 1-3 days, and can persist for up to 1 week following a single infusion [4]. They correlate with the alleviation of depressive symptoms.

Long-Term Effects:

Repeated ketamine administrations help sustain the heightened synaptic plasticity and DMN normalization over the longer term. Specifically:

  • Cross-network functional connectivity remains enhanced between DMN regions involved in self-referential thought [5].
  • Inverse coupling with neural networks involved in external attention is maintained, indicating increased cognitive flexibility [6].
  • The anti-correlated relationship between DMN and salience network persists, improving context-dependent shifting between internal mentation and external stimulus processing [7].

Together, these more permanent DMN effects may mediate and predict better outcomes months later, especially when ketamine is paired with additional antidepressant therapies.


[1] Abdallah CG, et al. Ketamine treatment and global brain connectivity in major depression. Neuropsychopharmacology. 2017;42(6):1210-1219. doi:10.1038/npp.2016.197

[2] Zanos P, et al. Ketamine and Ketamine Metabolite Pharmacology: Insights Into Therapeutic Mechanisms. Pharmacol Rev. 2018;70(3):621-660. doi:10.1124/pr.117.015198

[3] Scheidegger M, et al. Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action. PLoS One. 2012;7(9):e44799. doi:10.1371/journal.pone.0044799

[4] Abdallah CG, et al. Ketamine’s antidepressant efficacy is extended for at least four weeks with repeated infusions two weeks apart. Psychol Med. 2018;48(15):2692-2696. doi:10.1017/S003329171800103X

[5] Yang C, et al. Identification of ketamine response-related structural abnormalities in major depressive disorder using connectivity-informed parcellation. EBioMedicine. 2018;30:105-114. doi:10.1016/j.ebiom.2018.03.017

[6] Fonzo GA, et al. Ketamine-enhanced resting functional connectivity of the dorsomedial prefrontal cortex as a predictor of treatment response in major depressive disorder. Psychol Med. 2020;50(2):321-331. doi:10.1017/S0033291719000068

[7] Bittner RA, et al. Dysregulation of Salience Network Connectivity in Treatment-Resistant Depression: A Potential Marker of Persistent Symptoms. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(7):658-666. doi:10.1016/j.bpsc.2017.11.013


Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments